The price of Syros Pharmaceuticals Inc (NASDAQ:SYRS) shares last traded on Wall Street rose 39.24% to $0.28.
SYRS stock price is now -85.73% away from the 50-day moving average and -93.73% away from the 200-day moving average. The market capitalization of the company currently stands at $7.42M.
With the price target enhanced from $11 to $15, H.C. Wainwright Upgraded its rating from Neutral to Buy for Syros Pharmaceuticals Inc (NASDAQ: SYRS). On September 22, 2020, Alliance Global Partners recently initiated its ‘Buy’ rating on the stock quoting a target price of $18, while ‘Wedbush’ rates the stock as ‘Neutral’
In other news, Quirk Gerald E, Officer bought 46,657 shares of the company’s stock on Nov 19 ’24. The stock was bought for $10,323 at an average price of $0.22. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 18 ’24, Officer Haas Jason bought 37,803 shares of the business’s stock. A total of $8,669 was incurred on buying the stock at an average price of $0.23. A total of 37.06% of the company’s stock is owned by insiders.
During the past 12 months, Syros Pharmaceuticals Inc has had a low of $0.18 and a high of $8.17. The fifty day moving average price for SYRS is $1.96604 and a two-hundred day moving average price translates $4.451535 for the stock.
The latest earnings results from Syros Pharmaceuticals Inc (NASDAQ: SYRS) was released for 2024-09-30. The net profit margin was -25340.67% and return on equity was -776.96% for SYRS.
